127 related articles for article (PubMed ID: 3926660)
1. Two distinct human myeloma cell lines originating from one patient with myeloma.
Katagiri S; Yonezawa T; Kuyama J; Kanayama Y; Nishida K; Abe T; Tamaki T; Ohnishi M; Tarui S
Int J Cancer; 1985 Aug; 36(2):241-6. PubMed ID: 3926660
[TBL] [Abstract][Full Text] [Related]
2. Surface expression of human myeloma cells: an analysis using a panel of monoclonal antibodies.
Katagiri S; Yonezawa T; Tamaki T; Kanayama Y; Kuyama J; Ohnishi M; Tsubakio T; Kurata Y; Tarui S
Acta Haematol; 1984; 72(6):372-8. PubMed ID: 6442520
[TBL] [Abstract][Full Text] [Related]
3. A human myeloma cell line that does not express immunoglobulin but yields a high frequency of antibody-secreting hybridomas.
Pickering JW; Gelder FB
J Immunol; 1982 Jul; 129(1):406-12. PubMed ID: 6806365
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid effects on myeloma cells in culture: correlation of growth inhibition with induction of glucocorticoid receptor messenger RNA.
Gomi M; Moriwaki K; Katagiri S; Kurata Y; Thompson EB
Cancer Res; 1990 Mar; 50(6):1873-8. PubMed ID: 2106390
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of two human myeloma cell lines secreting kappa light chains.
Eton O; Scheinberg DA; Houghton AN
Leukemia; 1989 Oct; 3(10):729-35. PubMed ID: 2506399
[TBL] [Abstract][Full Text] [Related]
6. B-cell differentiation antigen expressed on a human myeloma cell line (KMM-1).
Togawa A; Inoue N; Mannoji M; Namba M
Jpn J Clin Oncol; 1983 Sep; 13(3):511-5. PubMed ID: 6417374
[TBL] [Abstract][Full Text] [Related]
7. Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD.
Gallart T; Bladé J; Martínez-Quesada J; Sierra J; Rozman C; Vives J
Immunology; 1985 May; 55(1):45-57. PubMed ID: 3922877
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a new human multiple myeloma cell line, UMJF-2, which suppresses antibody production by B-lymphocytes in vitro.
Farnen JP; Tyrkus M; Hanson CA; Cody RL; Emerson SG
Leukemia; 1991 Jul; 5(7):574-84. PubMed ID: 1649357
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma.
Shimazaki C; Fried J; Perez AG; Scheinberg DA; Atzpodien J; Wang CY; Wisniewolski R; Clarkson BD
Acta Haematol; 1990; 83(3):123-9. PubMed ID: 2109450
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of a new human Bence Jones-type myeloma cell line, NOP-2.
Nagai T; Ogura M; Morishita Y; Okumura M; Kato Y; Morishima Y; Hirabayashi N; Ohno R; Saito H
Int J Hematol; 1991 Apr; 54(2):141-9. PubMed ID: 1747447
[TBL] [Abstract][Full Text] [Related]
11. Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing delta/lambda type immunoglobulin.
Matsuo Y; Drexler HG; Harashima A; Okochi A; Hasegawa A; Kojima K; Orita K
Leuk Res; 2004 Aug; 28(8):869-77. PubMed ID: 15203285
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of immunoglobulin light chain isotype in B lymphocytes from patients with monoclonal gammopathies: isotypic discordance and clonal B-cell excess.
Oritani K; Katagiri S; Tominaga N; Iida M; Amano T; Karasuno T; Matsumura I; Mitsui H; Kanayama Y; Yonezawa T
Br J Haematol; 1990 May; 75(1):10-5. PubMed ID: 2115808
[TBL] [Abstract][Full Text] [Related]
13. Establishment of five human myeloma cell lines.
Namba M; Ohtsuki T; Mori M; Togawa A; Wada H; Sugihara T; Yawata Y; Kimoto T
In Vitro Cell Dev Biol; 1989 Aug; 25(8):723-9. PubMed ID: 2768132
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of a new human Burkitt's lymphoma cell line (WSU-BL).
Mohamed AN; Mohammad RM; Koop BF; al-Katib A
Cancer; 1989 Sep; 64(5):1041-8. PubMed ID: 2527086
[TBL] [Abstract][Full Text] [Related]
15. Multiple myeloma: circulating lymphocytes that express plasma cell antigens.
Ruiz-Argüelles GJ; Katzmann JA; Greipp PR; Gonchoroff NJ; Garton JP; Kyle RA
Blood; 1984 Aug; 64(2):352-6. PubMed ID: 6611178
[TBL] [Abstract][Full Text] [Related]
16. Analysis of surface antigen expression of human immunoglobulin-secreting cells: phenotypic heterogeneity in normal counterparts of myeloma cells.
Tominaga N; Katagiri S; Ohnishi M; Nakao H; Oritani K; Yagura H; Tamaki T; Kanayama Y; Yonezawa T; Tarui S
Br J Haematol; 1989 Nov; 73(3):302-8. PubMed ID: 2605119
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and functional analysis of B cell lines from patients with multiple myeloma.
Goldstein M; Hoxie J; Zembryki D; Matthews D; Levinson AI
Blood; 1985 Aug; 66(2):444-6. PubMed ID: 3893568
[TBL] [Abstract][Full Text] [Related]
18. Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma.
Preud'Homme JL; Hurez D; Danon F; Brouet JC; Seligmann M
Clin Exp Immunol; 1976 Sep; 25(3):428-36. PubMed ID: 822974
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel myeloma cell line, MM.1.
Goldman-Leikin RE; Salwen HR; Herst CV; Variakojis D; Bian ML; Le Beau MM; Selvanayagan P; Marder R; Anderson R; Weitzman S
J Lab Clin Med; 1989 Mar; 113(3):335-45. PubMed ID: 2926241
[TBL] [Abstract][Full Text] [Related]
20. Two monoclonal antibodies (OKIa1 and OKT10) for the study of the final B cell maturation.
Van Camp B; Thielemans C; Dehou MF; De Mey J; De Waele M
J Clin Immunol; 1982 Jul; 2(3 Suppl):67S-74S. PubMed ID: 6813349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]